In this study, we utilized GO nanosheets non‐covalently complexed with BTZ as a novel, single dose, intratumorally administered therapy, which achieved an enhanced anti‐cancer activity compared to the free drug in two orthotopic mouse models of glioblastoma. Here, CASC3 is linked to glioblastoma.